Ülke: İrlanda
Dil: İngilizce
Kaynak: HPRA (Health Products Regulatory Authority)
Perindopril tert-butylamine
Accord Healthcare Ireland Ltd.
C09AA; C09AA04
Perindopril tert-butylamine
4 milligram(s)
Tablet
Product subject to prescription which may be renewed (B)
ACE inhibitors, plain; perindopril
Marketed
2008-12-12
1 PACKAGE LEAFLET: INFORMATION FOR THE USER PERCARNIL 4 MG TABLETS PERCARNIL 8 MG TABLETS perindopril tert-butylamine READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Percarnil is and what is it used for 2. What you need to know before you take Percarnil 3. How to take Percarnil 4. Possible side effects 5. How to store Percarnil 6. Contents of the pack and other information 1. WHAT PERCARNIL IS AND WHAT IT IS USED FOR Percarnil contains the active substance perindopril tert-butylamine which belongs to a group of medicines called ACE inhibitors. These work by widening the blood vessels. This makes it easier for your heart to pump blood through the body. Percarnil 4 mg Tablets are used to: • treat high blood pressure (hypertension) • treat heart failure (a condition where the heart is unable to pump enough blood to meet the body’s needs) • reduce the risk of cardiac events, such as heart attack, in patients with stable coronary artery disease (a condition where the blood supply to the heart is reduced or blocked) and who have already had a heart attack and/or an operation to improve the blood supply to the heart by widening the vessels that supply it. Percarnil 8 mg Tablets are used to: • treat high blood pressure (hypertension) • reduce the risk of cardiac events, such as heart attack, in patients with stable coronary artery disease (a condition where the blood supply to the heart is reduced or blocked) and who have already had a heart attack and/or an operation to improve the blood su Belgenin tamamını okuyun
HealthProductsRegulatoryAuthority 31May2019 CRN008Z7N Page1of16 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Percarnil4mgTablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Eachtabletcontains: 4mgperindopriltert-butylaminesalt,equivalentto3.338mgperindopril Excipient with known effect: Eachtabletcontains62.78mgoflactosemonohydrate Forthefulllistofexcipients,seesection6.1. 3 PHARMACEUTICAL FORM Tablet White,oblongtablet,withabreak-lineonbothsides,‘PP’engravedononesideand‘4’ontheother. Thetabletcanbedividedintoequaldoses. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Hypertension: Treatmentofhypertension Heart failure: Treatmentofsymptomaticheartfailure Stable coronary artery disease Reductionofriskofcardiaceventsinpatientswithahistoryofmyocardialinfarctionand/orrevascularisation. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology Thedoseshouldbeindividualisedaccordingtothepatientprofile(seesection4.4)andbloodpressureresponse. _Hypertension_ Percarnilmaybeusedinmonotherapyorincombinationwithotherclassesofantihypertensivetherapy(seesections4.3,4.4, 4.5and5.1). Therecommendedstartingdoseis4mggivenoncedailyinthemorning. Patientswithastronglyactivatedrenin-angiotensin-aldosteronesystem(inparticular,renovascularhypertension,saltand/or volumedepletion,cardiacdecompensationorseverehypertension)mayexperienceanexcessivedropinbloodpressure followingtheinitialdose.Astartingdoseof2mgisrecommendedinsuchpatientsandtheinitiationoftreatmentshouldtake Belgenin tamamını okuyun